Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

NCT01529034 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
175
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Biopharma S.P.R.L.